Clinical Trials Directory

Trials / Terminated

TerminatedNCT02366988

The PASTEC Study: Endoscopic Stenting Versus Surgery for the Treatment of Bile Duct Stricture in Chronic Pancreatitis

Phase 3 Prospective, Multicentric Randomized Study of Endoscopic Versus Surgical Treatment of Bile Duct Stricture in Chronic Pancreatitis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Biliary obstruction complicates the course of chronic pancreatitis in 3%-23% of patients and in these cases, endoscopy and surgery are the treatment modalities of choice. Morbid-mortality of these procedures is similar and physicians face the decision between endoscopy and surgery for this group of patients, with no randomized controlled trial available comparing these procedures. The PASTEC trial is a multicenter, phase III, randomized, comparing the effectiveness of surgical and endoscopic interventions in the management of bile duct stricture for chronic pancreatitis. The primary end point is 18-months normalization of serum alkaline phosphatase. Secondary end points are morbid-mortality rate, quality of life, numbers of endoscopic or surgical procedures, length of stay. Eighty-six patients need to be included.

Detailed description

This study is planned to last for 4 years, with a 2-year inclusion period and a 2-year follow-up period.

Conditions

Interventions

TypeNameDescription
DEVICEEndoscopic Biliary StentingEndoscopic probe self-expandable metallic covered stent Biliary stent will be left in place for 6 months
PROCEDURESurgical treatment Bilio-enteric anastomosisBilio-enteric anastomosis including Whipple, Frey or Beger procedure, double or triple derivation

Timeline

Start date
2015-02-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2015-02-20
Last updated
2018-06-21

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02366988. Inclusion in this directory is not an endorsement.